Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Pessetto A"'
Autor:
Nan He, Sirisha Thippabhotla, Cuncong Zhong, Zachary Greenberg, Liang Xu, Ziyan Pessetto, Andrew K. Godwin, Yong Zeng, Mei He
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-12 (2022)
3D-structured nanographene immunomagnetic particles with flower pompoms morphology and photo-click chemistry are applied for specific marker-defined capture and release of exosomes from several types of biological fluids, identifying targetable cance
Externí odkaz:
https://doaj.org/article/239316d9e49942878c27877f1896a3da
Autor:
Britt, Alec, Mohyuddin, Ghulam Rehman *, McClune, Brian, Singh, Anurag, Lin, Tara, Ganguly, Siddhartha, Abhyankar, Sunil, Shune, Leyla, McGuirk, Joseph, Skikne, Barry, Godwin, Andrew, Pessetto, Ziyan, Golem, Shivani, Divine, Clint, Dias, Ajoy
Publikováno v:
In Leukemia Research August 2020 95
Autor:
Meizhang Li, Rupal Soder, Sunil Abhyankar, Haitham Abdelhakim, Mitchell W. Braun, Camille V. Trinidad, Harsh B. Pathak, Ziyan Pessetto, Clayton Deighan, Siddhartha Ganguly, Buddhadeb Dawn, Joseph McGuirk, Neil Dunavin, Andrew K. Godwin
Publikováno v:
Journal of Extracellular Vesicles, Vol 10, Iss 4, Pp n/a-n/a (2021)
Abstract Both mesenchymal stem cells (MSCs) and their corresponding small extracellular vesicles (sEVs, commonly referred to as exosomes) share similar immunomodulatory properties that are potentially beneficial for the treatment of acute graft versu
Externí odkaz:
https://doaj.org/article/21f1166dd8c24d04b0b82445de312aa4
Autor:
Mitchell W Braun, Haitham Abdelhakim, Meizhang Li, Stephen Hyter, Ziyan Pessetto, Devin C Koestler, Harsh B Pathak, Neil Dunavin, Andrew K Godwin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Tumor-infiltrating lymphocyte (TIL) therapy is a personalized cancer treatment which involves generating ex vivo cultures of tumor-reactive T cells from surgically resected tumors and administering the expanded TILs as a therapeutic infusi
Externí odkaz:
https://doaj.org/article/f57163bea55a4ccd892dc04bd9ee8fc1
Autor:
Dai, Hongyan, Gallagher, Dan, Schmitt, Sarah, Pessetto, Ziyan Y., Fan, Fang, Godwin, Andrew K., Tawfik, Ossama
Publikováno v:
In Human Pathology March 2017 61:68-77
PDF file - 1279K, Table S1: List of FDA-approved drug library; Table S2: Screen parameters; Table S3: Curve classification criteria; Table S4: Screening of FDA-approved drugs on Hs 919.T. cell line hits summary; Table S5: Drug structures of candidate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a335ab44ca519c5890a4575727d96c
https://doi.org/10.1158/1535-7163.22499692.v1
https://doi.org/10.1158/1535-7163.22499692.v1
Autor:
Andrew K. Godwin, Scott J. Weir, Margaret von Mehren, Jeff J. Hirst, Yan Ma, Ziyan Y. Pessetto
Gastrointestinal stromal tumor (GIST) is a rare and therefore often neglected disease. Introduction of the kinase inhibitor imatinib mesylate radically improved the clinical response of patients with GIST; however, its effects are often short-lived,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91f5c74e0ab6ca8149686ccf1aa2f9b5
https://doi.org/10.1158/1535-7163.c.6536842.v1
https://doi.org/10.1158/1535-7163.c.6536842.v1
Despite significant treatment advances over the past decade, metastatic gastrointestinal stromal tumor (GIST) remains largely incurable. Rare diseases, such as GIST, individually affect small groups of patients but collectively are estimated to affec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c490df5a6b47a9d599a1b71c15419f09
https://doi.org/10.1158/1535-7163.c.6536224
https://doi.org/10.1158/1535-7163.c.6536224
Autor:
Andrew K. Godwin, Scott J. Weir, Margaret von Mehren, Jeff J. Hirst, Yan Ma, Ziyan Y. Pessetto
Figure S1. Analysis of combination index (CI) value of IM combined with FDA-approved drugs in GIST-T1 cells. Figure S2. Analysis of CI value of IM combined with FDA-approved drugs in GIST 882 cells. Figure S3. Analysis of CI value of IM combined with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::247fb5b93e3853cbff307ac938a79e30
https://doi.org/10.1158/1535-7163.22501606.v1
https://doi.org/10.1158/1535-7163.22501606.v1
Autor:
Maxine Kugelmas, Isain Zapata, Jose Tawil, Annelisa Pessetto, Michael Taglienti, Marcelo Kugelmas
Publikováno v:
Digestive Diseases and Sciences. 68:931-938
To analyze our experience with adenoma detection rates in patients with liver cirrhosis in a community setting.Colorectal cancer (CRC) is the third most common cancer and leading cause of cancer death in men and women in the USA. The majority of CRCs